Related references
Note: Only part of the references are listed.Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence
Carey E. Gleason et al.
ALZHEIMERS & DEMENTIA (2022)
The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment
Shana D. Stites et al.
SOCIAL SCIENCE & MEDICINE (2022)
Bringing Alzheimer Disease Testing and Results Disclosure Into the 21st Century Cures Act
Emily A. Largent et al.
JAMA NEUROLOGY (2022)
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
Joel Simren et al.
ALZHEIMERS & DEMENTIA (2021)
The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests
Emily A. Largent et al.
JAMA NEUROLOGY (2021)
Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences
Claire M. Erickson et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)
Family members' perspectives on learning cognitively unimpaired older adults' amyloid-β PET scan results
Emily A. Largent et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)
Disclosure of individual research results at federally funded Alzheimer's Disease Research Centers
J. Scott Roberts et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)
'That would be dreadful': The ethical, legal, and social challenges of sharing your Alzheimer's disease biomarker and genetic testing results with others
Emily A. Largent et al.
JOURNAL OF LAW AND THE BIOSCIENCES (2021)
Aducanumab: Appropriate Use Recommendations
J. Cummings et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2021)
Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
Claire M. Erickson et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)
General practitioners' attitude toward early and pre-dementia diagnosis of AD in five European countries-A MOPEAD project survey
Lena Sannemann et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)
Confidential genetic testing and electronic health records: A survey of current practices among Huntington disease testing centers
Celeste C. Eno et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2020)
Disclosure of Amyloid Status for Risk of Alzheimer Disease to Cognitively Normal Research Participants With Subjective Cognitive Decline: A Longitudinal Study
Taisei Wake et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2020)
Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results
Emily A. Largent et al.
PLOS ONE (2020)
Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals
Reisa A. Sperling et al.
JAMA NEUROLOGY (2020)
Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment
Joshua D. Grill et al.
JAMA NEUROLOGY (2020)
Huntington disease: A quarter century of progress since the gene discovery
Claudia M. Testa et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Huntington's disease in the United States: Variation by demographic and socioeconomic factors
Emilie Bruzelius et al.
MOVEMENT DISORDERS (2019)
Patient Stakeholder Versus Physician Preferences Regarding Amyloid PET Testing
Melissa J. Armstrong et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2019)
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
Ganesh M. Babulal et al.
ALZHEIMERS & DEMENTIA (2019)
Biomarkers for Alzheimer Dementia in Diverse Racial and Ethnic Minorities-A Public Health Priority
Lisa L. Barnes
JAMA NEUROLOGY (2019)
The National Institute on Minority Health and Health Disparities Research Framework
Jennifer Alvidrez et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2019)
Association between enrollment factors and incident cognitive impairment in Blacks and Whites: Data from the Alzheimer's Disease Center
Carey E. Gleason et al.
ALZHEIMERS & DEMENTIA (2019)
Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials
Carolyn M. Langlois et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease
Ron Brookmeyer et al.
ALZHEIMERS & DEMENTIA (2018)
Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States
Ron Brookmeyer et al.
ALZHEIMERS & DEMENTIA (2018)
What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the US general public
Shana D. Stites et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults
Jessica Mozersky et al.
JAMA NEUROLOGY (2018)
Genetic counseling and testing for Huntington's disease: A historical review
Martha A. Nance
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2017)
Safety of disclosing amyloid status in cognitively normal older adults
Jeffrey M. Burns et al.
ALZHEIMERS & DEMENTIA (2017)
Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability
Yen Ying Lim et al.
ALZHEIMERS & DEMENTIA (2016)
Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials
Joshua D. Grill et al.
NEUROBIOLOGY OF AGING (2016)
Legal consequences and protections: Challenges for documenting preclinical biomarkers in patients' medical records
Jalayne J. Arias et al.
Alzheimers & Dementia (2015)
Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results
Jonathan Gooblar et al.
JAMA NEUROLOGY (2015)
Effect of Knowledge of APOE Genotype on Subjective and Objective Memory Performance in Healthy Older Adults
Tara T. Lineweaver et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Public Perceptions of Presymptomatic Testing for Alzheimer Disease
Richard J. Caselli et al.
MAYO CLINIC PROCEEDINGS (2014)
Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Keith A. Johnson et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Using AD biomarker research results for clinical care A survey of ADNI investigators
Melanie B. Shulman et al.
NEUROLOGY (2013)
Estimating and communicating prognosis in advanced neurologic disease
Robert G. Holloway et al.
NEUROLOGY (2013)
Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease
Elizabeth M. Wikler et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease
J. Scott Roberts et al.
GENETICS IN MEDICINE (2012)
Dementia care in rural and remote settings: A systematic review of informal/family caregiving
Anthea Innes et al.
MATURITAS (2011)
Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease
Jason Karlawish
NEUROLOGY (2011)
Informed choice in direct-to-consumer genetic testing for Alzheimer and other diseases: lessons from two cases
Donna A. Messner
NEW GENETICS AND SOCIETY (2011)
How do we achieve informed choice for women considering breast screening?
Jolyn Hersch et al.
PREVENTIVE MEDICINE (2011)
Disclosure of APOE Genotype for Risk of Alzheimer's Disease
Robert C. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Partners of mutation-carriers for Huntington's disease: forgotten persons?
M Decruyenaere et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2005)
Adverse effects of predictive testing for Huntington disease underestimated: Long-term effects 7-10 years after the test
R Timman et al.
HEALTH PSYCHOLOGY (2004)
Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial
JS Roberts et al.
GENETICS IN MEDICINE (2004)
Cancer screening in elderly patients - A framework for individualized decision making
LC Walter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Psychological consequences of predictive genetic testing: a systematic review
M Broadstock et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
